{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "marketState": "CLOSED", "regularMarketChangePercent": 17.459358, "regularMarketPrice": 9.755, "exchange": "LSE", "shortName": "SYNAIRGEN PLC ORD 1P", "longName": "Synairgen plc", "messageBoardId": "finmb_20361040", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketTime": 1683905085, "earningsTimestamp": 1682593140, "earningsTimestampStart": 1682593140, "earningsTimestampEnd": 1682593140, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.09, "epsForward": -2.98, "epsCurrentYear": -5.03, "priceEpsCurrentYear": -1.9393637, "sharesOutstanding": 201375008, "bookValue": 0.101, "fiftyDayAverage": 10.11956, "fiftyDayAverageChange": -0.36456013, "fiftyDayAverageChangePercent": -0.036025293, "twoHundredDayAverage": 16.088915, "twoHundredDayAverageChange": -6.3339148, "twoHundredDayAverageChangePercent": -0.3936819, "marketCap": 19644132, "forwardPE": -0.0327349, "priceToBook": 96.58416, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1098774000000, "priceHint": 2, "regularMarketChange": 1.4499998, "regularMarketDayHigh": 11.0, "regularMarketDayRange": "8.01 - 11.0", "regularMarketDayLow": 8.01, "regularMarketVolume": 1091629, "regularMarketPreviousClose": 8.305, "bid": 9.01, "ask": 10.5, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "GBP", "regularMarketOpen": 9.9306, "averageDailyVolume3Month": 635949, "averageDailyVolume10Day": 569885, "fiftyTwoWeekLowChange": 2.745, "fiftyTwoWeekLowChangePercent": 0.3915834, "fiftyTwoWeekRange": "7.01 - 43.98", "fiftyTwoWeekHighChange": -34.225, "fiftyTwoWeekHighChangePercent": -0.7781946, "fiftyTwoWeekLow": 7.01, "fiftyTwoWeekHigh": 43.98, "symbol": "SNG.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Mailpoint 810", "address2": "Level F, South Block Southampton General Hospital Tremona Road", "city": "Southampton", "zip": "SO16 6YD", "country": "United Kingdom", "phone": "44 23 8051 2800", "fax": "44 23 8051 2800", "website": "https://www.synairgen.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-\u00df), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-\u00df that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard  Marsden", "age": 54, "title": "CEO, MD & Exec. Director", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 1022000, "fmt": "1.02M", "longFmt": "1,022,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1823469, "fmt": "1.82M", "longFmt": "1,823,469"}}, {"maxAge": 1, "name": "Prof. Stephen T. Holgate CBE, M.D.", "age": 74, "title": "Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board", "yearBorn": 1948, "fiscalYear": 2021, "totalPay": {"raw": 30000, "fmt": "30k", "longFmt": "30,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Ward", "age": 60, "title": "CFO & Exec. Director", "yearBorn": 1962, "fiscalYear": 2021, "totalPay": {"raw": 887000, "fmt": "887k", "longFmt": "887,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1418254, "fmt": "1.42M", "longFmt": "1,418,254"}}, {"maxAge": 1, "name": "Dr. Phillip David Monk", "age": 53, "title": "Chairman of Scientific Advisory Board, Chief Scientific Officer & Exec. Director", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": {"raw": 758000, "fmt": "758k", "longFmt": "758,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1316951, "fmt": "1.32M", "longFmt": "1,316,951"}}, {"maxAge": 1, "name": "Prof. Donna  Davies", "title": "Co-Founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Ratko  Djukanovic", "title": "Co-Founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Brooke S Clarke", "title": "Sr. VP & Head of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gareth E. Walters Ph.D.", "age": 63, "title": "Chief Regulatory Officer", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jody  Brookes", "title": "Sr. VP & Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard  Hennings", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}